Replication Data for: CVA ketenindicator

In this cross-sectional study data were collected in individuals with stroke 3 months after stroke onset. Inclusion took place in 6 Dutch hospitals between September 2017 and September 2018. Individuals who had suffered a stroke and were admitted to one of the stroke units of the six participating hospitals were eligible for inclusion. All individuals with stroke received a letter informing them about this study, after which informed consent was acquired. The EQ-5D-5L, PROMIS-10, mRS, self-reported decrease in health post-stroke and self-reported decrease in activities post-stroke were administered by a stroke nurse or nurse practitioner at the outpatient clinic through a telephone interview 3 months after stroke. The stroke nurses and nurse practitioners were already trained to perform telephone interviews as part of regular follow-up assessments after stroke. Before the start of the study, all stroke nurses and nurse practitioners were provided with the same instructions about the use of the extra questionnaires to screen for the consequences of stroke, including information on possibilities to elucidate certain questions to the patients. An interview took on average 30 minutes. Demographic (sex, age, marital status, residency and level of education) and strokerelated information (type and localization of stroke, severity of stroke, ADL-dependency) were obtained from medical records by the stroke nurse. The Medical Ethics Committee of the University Medical Center Utrecht declared that the study did not need formal approval under Dutch law (2017-441C). All participating hospitals approved the study.